These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 10704334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.
    Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770
    [Abstract] [Full Text] [Related]

  • 3. Specific interactions between HIV-1 nucleocapsid protein and the TAR element.
    Kanevsky I, Chaminade F, Ficheux D, Moumen A, Gorelick R, Negroni M, Darlix JL, Fossé P.
    J Mol Biol; 2005 May 20; 348(5):1059-77. PubMed ID: 15854644
    [Abstract] [Full Text] [Related]

  • 4. Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis.
    Beltz H, Clauss C, Piémont E, Ficheux D, Gorelick RJ, Roques B, Gabus C, Darlix JL, de Rocquigny H, Mély Y.
    J Mol Biol; 2005 May 20; 348(5):1113-26. PubMed ID: 15854648
    [Abstract] [Full Text] [Related]

  • 5. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L, Yu XF.
    Virology; 1998 Nov 10; 251(1):141-57. PubMed ID: 9813210
    [Abstract] [Full Text] [Related]

  • 6. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
    Gorelick RJ, Gagliardi TD, Bosche WJ, Wiltrout TA, Coren LV, Chabot DJ, Lifson JD, Henderson LE, Arthur LO.
    Virology; 1999 Mar 30; 256(1):92-104. PubMed ID: 10087230
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence.
    Bernacchi S, Stoylov S, Piémont E, Ficheux D, Roques BP, Darlix JL, Mély Y.
    J Mol Biol; 2002 Mar 29; 317(3):385-99. PubMed ID: 11922672
    [Abstract] [Full Text] [Related]

  • 8. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
    Yurochko AD, Huong SM, Huang ES.
    J Hum Virol; 1999 Mar 29; 2(2):81-90. PubMed ID: 10225210
    [Abstract] [Full Text] [Related]

  • 9. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability.
    Lapadat-Tapolsky M, Gabus C, Rau M, Darlix JL.
    J Mol Biol; 1997 May 02; 268(2):250-60. PubMed ID: 9159468
    [Abstract] [Full Text] [Related]

  • 10. Regulation of HIV-1 gene expression by NF-IL6.
    Tesmer VM, Bina M.
    J Mol Biol; 1996 Sep 27; 262(3):327-35. PubMed ID: 8844998
    [Abstract] [Full Text] [Related]

  • 11. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
    Vlach J, Garcia A, Jacqué JM, Rodriguez MS, Michelson S, Virelizier JL.
    Virology; 1995 Apr 20; 208(2):753-61. PubMed ID: 7747447
    [Abstract] [Full Text] [Related]

  • 12. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
    Huang M, Maynard A, Turpin JA, Graham L, Janini GM, Covell DG, Rice WG.
    J Med Chem; 1998 Apr 23; 41(9):1371-81. PubMed ID: 9554870
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons.
    Miller SC, Taylor A, Watanabe K, Mok K, Torti FM.
    Exp Cell Res; 1997 Jan 10; 230(1):9-21. PubMed ID: 9013701
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J, Tenbaum SP, Castillo AI, Sánchez-Pacheco A, Aranda A.
    J Mol Endocrinol; 2007 Jun 10; 38(6):587-601. PubMed ID: 17556530
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor.
    Dreikhausen U, Hiebenthal-Millow K, Bartels M, Resch K, Nourbakhsh M.
    Mol Cell Biol; 2005 Sep 10; 25(17):7473-83. PubMed ID: 16107696
    [Abstract] [Full Text] [Related]

  • 20. Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function.
    Urbaneja MA, Kane BP, Johnson DG, Gorelick RJ, Henderson LE, Casas-Finet JR.
    J Mol Biol; 1999 Mar 19; 287(1):59-75. PubMed ID: 10074407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.